Noninvasive prenatal testing for 22q11.2 deletion syndrome: Deeper sequencing increases the positive predictive value

American Journal of Obstetrics and Gynecology

Volumn 213, Issue 2, 2015, Pages 254-255

  Gross, Susan J ^a   Ryan, Allison ^a   Benn, Peter ^b  

^a NATERA INC   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAT CRY SYNDROME; CHROMOSOME DELETION 22Q11; GENE SEQUENCE; HIGH RISK PATIENT; HUMAN; LETTER; LOW RISK PATIENT; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME DELETION; CHROMOSOME DISORDERS; FEMALE; GENETIC SCREENING; MATERNAL SERUM SCREENING TEST; PREGNANCY; PROCEDURES;

CHROMOSOME DELETION; CHROMOSOME DISORDERS; FEMALE; GENETIC TESTING; HUMANS; MATERNAL SERUM SCREENING TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 84937968977     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.05.028     Document Type: Letter

References (1)

1. R.J. Wapner, J.E. Babiarz, B. Levy, and et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes Am J Obstet Gynecol 212 2015 332.e1 332.e9